Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial-Reference-Cited by-同舟云学术

Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial

Published:1990-01 Issue:1 Volume:2 Page:27-34
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Ribeiro G.G.,Dunn Gillian,Swindell R.,Harris M.,Banerjee S.S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference15 articles.

1. Histological grading and prognosis in breast carcinoma;Bloom;British Journal of Cancer,1957

2. Experience with breast conserving approaches at the Curie Institute;Calle,1985

3. Management of ‘early’ cancer of the breast. Report on an international multicentre trial supported by the CRC;Cancer Research Campaign Working Party;British Medical Journal,1976

4. Breast Cancer: A 21-year experience with conservative surgery and radiation;Clark;International Journal of Radiation Oncology, Biology, Physics,1982

5. Five-year results of a randomised clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer;Fisher;New England Journal of Medicine,1985

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Meta-Analysis of Trials of Partial Breast Irradiation;International Journal of Radiation Oncology*Biology*Physics;2023-01

2. Modern Radiation Therapy Techniques and their Toxicities for Breast Cancer;Breast Cancer: From Bench to Personalized Medicine;2022

3. Impact of Post-Mastectomy Radiation Therapy for Sentinel Lymph Node Micrometastases in Early-Stage Breast Cancer Patients;Medical Science Monitor;2021-10-25

4. Partial breast irradiation versus whole breast radiotherapy for early breast cancer;Cochrane Database of Systematic Reviews;2021-08-30

5. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial;The Lancet Oncology;2021-05